Analysis of upfront resection or stereotactic radiosurgery for local control of solid and cystic cerebellar hemangioblastomas

医学 放射外科 血管母细胞瘤 单变量分析 外科 肿瘤进展 回顾性队列研究 多元分析 放射科 癌症 放射治疗 内科学
作者
Luis R. Carrete,Ramin A. Morshed,Jacob S. Young,Lauro N. Avalos,Penny K. Sneed,Manish K. Aghi,Michael W. McDermott,Philip V. Theodosopoulos
出处
期刊:Journal of Neurosurgery [American Association of Neurological Surgeons]
卷期号:140 (2): 404-411 被引量:2
标识
DOI:10.3171/2023.6.jns222629
摘要

OBJECTIVE The purpose of this study was to identify rates of and risk factors for local tumor progression in patients who had undergone surgery or radiosurgery for the management of cerebellar hemangioblastoma and to describe treatments pursued following tumor progression. METHODS The authors conducted a retrospective single-center review of patients who had undergone treatment of a cerebellar hemangioblastoma with either surgery or stereotactic radiosurgery (SRS) between 1996 and 2019. Univariate and multivariate regression analyses were performed to examine factors associated with local tumor control. RESULTS One hundred nine patients met the study inclusion criteria. Overall, these patients had a total of 577 hemangioblastomas, 229 of which were located in the cerebellum. The surgical and SRS cohorts consisted of 106 and 123 cerebellar hemangioblastomas, respectively. For patients undergoing surgery, tumors were treated with subtotal resection and gross-total resection in 5.7% and 94.3% of cases, respectively. For patients receiving SRS, the mean target volume was 0.71 cm 3 and the mean margin dose was 18.0 Gy. Five-year freedom from lesion progression for the surgical and SRS groups was 99% and 82%, respectively. The surgical and SRS cohorts contained 32% versus 97% von Hippel–Lindau tumors, 78% versus 7% cystic hemangioblastomas, and 12.8- versus 0.56-cm 3 mean tumor volumes, respectively. On multivariate analysis, factors associated with local tumor progression in the SRS group included older patient age (HR 1.06, 95% CI 1.03–1.09, p < 0.001) and a cystic component (HR 9.0, 95% CI 2.03–32.0, p = 0.001). Repeat SRS as salvage therapy was used more often for smaller tumor recurrences, and no tumor recurrences of < 1.0 cm 3 required additional salvage surgery following repeat SRS. CONCLUSIONS Both surgery and SRS achieve high rates of local control of hemangioblastomas. Age and cystic features are associated with local progression after SRS treatment for cerebellar hemangioblastomas. In cases of local tumor recurrence, salvage surgery and repeat SRS are valid forms of treatment to achieve local tumor control, although resection may be preferable for larger recurrences.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雀巢早生蚝发布了新的文献求助100
刚刚
海绵宝宝完成签到,获得积分10
刚刚
orixero应助筷碗采纳,获得10
1秒前
mayun95发布了新的文献求助10
1秒前
2秒前
雍以菱发布了新的文献求助10
2秒前
2秒前
紫菜发布了新的文献求助10
2秒前
玄学小生完成签到,获得积分10
2秒前
xmg完成签到,获得积分20
3秒前
小熊猫完成签到,获得积分10
3秒前
3秒前
4秒前
情怀应助ff采纳,获得30
4秒前
岸上牛完成签到,获得积分10
4秒前
5秒前
小绵羊发布了新的文献求助10
5秒前
6秒前
科研通AI6.4应助zhuhaot采纳,获得50
6秒前
7秒前
7秒前
上官若男应助木光采纳,获得10
7秒前
halo发布了新的文献求助10
7秒前
pluto应助EricShen采纳,获得10
8秒前
香蕉觅云应助opp采纳,获得10
8秒前
8秒前
小胖饼饼完成签到,获得积分10
8秒前
SciGPT应助xmg采纳,获得10
9秒前
10秒前
11秒前
华仔应助aump采纳,获得10
11秒前
三徙教完成签到,获得积分10
12秒前
12秒前
小二郎应助jjhh采纳,获得10
12秒前
13秒前
14秒前
gaoyingxin发布了新的文献求助10
16秒前
16秒前
眉间一把刀完成签到,获得积分10
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Wolffs Headache and Other Head Pain 9th Edition 1000
Continuing Syntax 1000
Signals, Systems, and Signal Processing 510
Effect of Betaine on Growth Performance, Nutrients Digestibility, Blood Cells, Meat Quality and Organ Weights in Broiler Chicks 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6235323
求助须知:如何正确求助?哪些是违规求助? 8058958
关于积分的说明 16814306
捐赠科研通 5315255
什么是DOI,文献DOI怎么找? 2830996
邀请新用户注册赠送积分活动 1808434
关于科研通互助平台的介绍 1665807